Client
- Name
- NOVARTIS
- Location
- District of Columbia · United States of America
Registrant
- Firm
- NOVARTIS
- Description
- Federal Government Relations/Legislative Affairs
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
7 issuesBudget/Appropriations
H.R. 5371: Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 Funding for FDA - FY 2026 Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2026 FY 2026 President's Budget Request Inflation Reduction Act of 2022 (P.L. 117-169) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 Federal Budget Funding for National Institutes of Health - FY 2026 Appropriations H.R. 1: One Big Beautiful Bill Act (P.L. 119-21) FY 2027 President's Budget H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75)
LobbyistsJOSEPH MCGOWAN · TAYLOR BOOTH · COURTNEY LEE-ASHLEY · COURTNEY PIRON · SARAH DURR · PETER STEHOUWER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · White House Office · Office of Management & Budget (OMB) · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)
Copyright/Patent/Trademark
S. 43: Skinny Labels, Big Savings Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 2276/HR. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues Patent eligibility policy issues S. 1546/H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) Restrictions on Intellectual Property Rights PTAB reform Patent fee policy issues Section 101 reform
